Breaking News

You are here » Indian-Commodity  :  Investment  :  ICRA upgrades ratings assigned to Cholamandalam Investment's bank loan facilities

27-Apr2018

ICRA upgrades ratings assigned to Cholamandalam Investment's bank loan facilities

Credit rating agency, ICRA has upgraded rating assigned to Cholamandalam Investment and Finance Company's term loan worth Rs 10,213.66 crore to 'AA+' from 'AA-' and upgraded rating of NCDs worth Rs 12,968.20 crore to 'AA+' from 'AA-'.

The rating agency has also upgraded rating assigned to the company's perpetual debt worth Rs 1,330 crore to 'AA' from 'AA-' and has reaffirmed the rating of the Commercial Paper worth Rs 6,000 to 'A1+'.

Cholamandalam Investment and Finance Company is among the top 5 NBFC's in the country operating in vehicle finance, home equity, corporate and mortgage finance segments with subsidiaries in the broking and wealth advisory space.


Related News

View all news

Ganesh Films acquires distribution rights for 'Ezhumin'

Ganesh Films India has acquired the sole theatrical distribution rights for North India region from Vaiyam Mediyas for Tamil language movie 'Ezhumin'. It is an upcoming Tamil language movie based on importance......

Reliance Industries' arm acquires stake in SkyTran

Reliance Industries' (RIL) wholly owned subsidiary -- Reliance Industrial Investments and Holdings has successfully acquired 12.7% shareholding (on fully diluted basis) in SkyTran Inc. (SkyTran), a US......

Manomay Tex India to avail credit facilities up to Rs 80.62 crore from Consortium Bank

Manomay Tex India has received an approval for availing Credit Facilities up to Rs 80.62 crore from Consortium Bank i.e. State Bank of India (Lead Bank), Industrial Estate Branch, Bhilwara and Oriental......

Top News

View all news

Bhansali Engineering Polymers reports 33% fall in Q2 net profit

Bhansali Engineering Polymers has reported results for second quarter ended September 30, 2018.The company has reported 32.71% fall in its net profit at Rs 16.89 crore for the quarter under review as compared......

Biocon, Mylan N.V. receive positive CHMP opinion for Ogivri

Biocon and Mylan N.V. have announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Ogivri, a biosimilar......

Lupin Neurosciences receives positive CHMP opinion for NaMuscla

Lupin Neurosciences, a specialty pharma division of Lupin has announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA),......